Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

WW Domain-Containing Oxidoreductase × Breast × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Head & Neck 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Fulvestrant 71 pembrolizumab 69 Letrozole 67 Paclitaxel 62 Trastuzumab 60 Specimen Handling 48 Capecitabine 45 Magnetic Resonance Spectroscopy 43 Tamoxifen 41 Anastrozole 39 pertuzumab 37 abemaciclib 37 Carboplatin 37 ribociclib 36 Cyclophosphamide 36 Biopsy 36 exemestane 34 palbociclib 30 Radiotherapy 28 Docetaxel 27 olaparib 26 trastuzumab deruxtecan 25 130-nm albumin-bound paclitaxel 23 Surveys and Questionnaires 22 eribulin 20 Doxorubicin 19 Taxes 18 Gemcitabine 18 Blood Specimen Collection 18 Standard of Care 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07394946 2026-02-20

NELOPHER

Cancer Care Hospital & Research Centre Foundation, Lahore

Phase 2 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡